DYD Unveils Saliva-Based Diabetes Diagnostic Kit... "Measures Glycated Albumin in 1 Minute"
Saliva-based glycated albumin diagnostic kit that DYD is preparing for mass production. Provided by DYD
View original imageDYD publicly unveiled for the first time a saliva-based glycated albumin diagnostic kit, which is currently being prepared for mass production, at a corporate briefing held on the 11th. The glycated albumin diagnostic kit revealed on this day is a product that can diagnose diabetes using only saliva tests instead of the conventional blood test method, and it is explained that glycated albumin can be measured in just one minute.
At the briefing, DYD announced plans for mass production of the diagnostic kit. The development of the core component of the diagnostic kit, the semiconductor wafer, has already been completed, and optimization for product mass production has been finalized. A plan for the mass production phase has also been established. Over the next 3 to 4 months, prototype production, performance evaluation, and clinical preparation will commence.
The company signed a business agreement last month with Gangwon Special Self-Governing Province and medical device manufacturer MIJ to establish a bio-semiconductor production base.
The importance of developing diagnostic kits using semiconductors was also mentioned at the briefing. DYD highlighted that using semiconductor wafers in the diagnostic kit eliminates the need for a separate amplification process and offers high applicability of the underlying technology. Additionally, it emphasized that this approach is very advantageous in terms of cost.
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
Meanwhile, DYD is pursuing approval from the U.S. Food and Drug Administration (FDA) for the saliva-based glycated albumin diagnostic kit. To this end, it recently pursued a business agreement with Montgomery County, Maryland, where the U.S. FDA headquarters is located.
Kim Young-deok, CEO, presenting at the DYD corporate briefing held on the 11th. Photo by DYD
View original image© The Asia Business Daily(www.asiae.co.kr). All rights reserved.